The advertisement promotes Eliquis, a medication designed to reduce the risk of stroke and blood clots in patients with atrial fibrillation, while also providing important safety warnings regarding its use.
Creative Information
| CID: | 3894a452-e035-4c5f-95c2-6cc35d31821a |
| CRID: | 92_5528:219374 |
| Domain: | eliquis.com |
| Seat: | RBC |
| Size: | 728x90 |
| Bid: | $1.14 |
| Timestamp: | 11/18/2025, 9:55:32 PM |
| Declared IAB Categories: |
Analysis
5 succeeded(100% complete)
| Task | Status | Last Updated | Duration | Actions |
|---|---|---|---|---|
| ad_analysis | success | 11/19/2025, 1:33:16 AM | 5.63s | |
| adomain_analysis | success | 11/19/2025, 1:32:37 AM | 4.37s | |
| adomain_capture | success | 11/19/2025, 1:32:33 AM | 0.14s | |
| ad_render | success | 11/19/2025, 1:33:10 AM | 18.68s | |
| brand_mapping | success | 11/18/2025, 9:55:33 PM | 0.10s | |
Analysis Results
| Size: | 728x90 | ||||||||||||||||||||||
| Data Transferred: | 1625.05 KB | ||||||||||||||||||||||
| Render Time: | 9.91 Seconds | ||||||||||||||||||||||
| Creative Inferred IAB Categories: |
| ||||||||||||||||||||||
| Creative Inferred IAB Ad Products: |
| ||||||||||||||||||||||
| Domain Inferred IAB Categories: |
| ||||||||||||||||||||||
| Domain Inferred IAB Ad Products: |
| ||||||||||||||||||||||
| Total Ad Size: | 1625.05 KB | ||||||||||||||||||||||
| Requests Made: |
|
Advertiser Domain

Ad Preview
Raw Ad Markup
<div data-rp-type="trp-display-creative" data-rp-impression-id="825bed53-8736-45cb-bec5-d9586eab384a" data-rp-aqid="5528:219374" data-rp-acct-id="11864"><div style="width: 0; height: 0; overflow: hidden;"><img border="0" width="1" height="1" src="https://useast-beacon.deepintent.com/impression/e6a44c05-028a-23b8-6d78-370f8f714f73?ts=1762992395645&wp=79C4F08F22A85244" alt="" /><img border="0" width="1" height="1" src="https://beacon-iad6.rubiconproject.com/beacon/d/825bed53-8736-45cb-bec5-d9586eab384a?oo=0&accountId=11864&siteId=229562&zoneId=1708178&sizeId=2&e=6A1E40E384DA563B24709E1472DA8F9D9D255E8A10F733CAE06AFB2ADB2D00EB6C1DBE9B3C801C273F22673C900ED3DD7956EDACF5AADE57A19495700DE53FBA41EBC1A76887AEB05FC5B167DD54DF0F464EC2B9960F434C8D06F8FE66608617D6F2840C16CEE75838F2B21A7B0A5DC8110DC8564FD78DCF9ACF8C2CB8BCBD6E95BD82A3F831953167A690D1B5B4C2C1F963915759077E4A3043A8E06C35A7165067C111FA71F2328E006D059EDAA9BA450C6AE9600D71EF" alt="" /></div>
<span id='deepintent_wrapper_1' onclick=DeepIntentExecuteClicks('')><div style='display:inline-block;position:relative;height:90px'><script type='text/javascript'>document.addEventListener('DOMContentLoaded',function(){setTimeout(function(){new Image().src='https://useast-beacon.deepintent.com/vi?impid=e6a44c05-028a-23b8-6d78-370f8f714f73&spanlen='+ (document.getElementById('deepintent_wrapper_span_e-88e7-730e-bc11-9700625d17cc').innerHTML.length) + '&spanelemcnt=' + (document.getElementById('deepintent_wrapper_span_e-88e7-730e-bc11-9700625d17cc').getElementsByTagName('*').length);},3000)});</script><span id='deepintent_wrapper_span_e-88e7-730e-bc11-9700625d17cc'><ins class='dcmads' style='display:inline-block;width:728px;height:90px' data-dcm-placement='N2123577.3219362APEXDEALS/B32886535.422560839' data-dcm-rendering-mode='script' data-dcm-landing-page-escapes='2' data-dcm-click-tracker='https://useast-beacon.deepintent.com/click/e6a44c05-028a-23b8-6d78-370f8f714f73?ts=1762992395645&wp=79C4F08F22A85244&loc=1&r=' data-dcm-https-only data-dcm-api-frameworks='[APIFRAMEWORKS]' data-dcm-omid-partner='[OMIDPARTNER]' data-dcm-gdpr-applies='gdpr=' data-dcm-gdpr-consent='gdpr_consent=' data-dcm-addtl-consent='addtl_consent=${ADDTL_CONSENT}' data-dcm-ltd='false' data-dcm-resettable-device-id='' data-dcm-app-id='' data-dcm-param-dvs1='1' data-dcm-param-dvs2='${SOURCE_URL_ENC}' data-dcm-param-dvs3='214763' data-dcm-param-dvs4='4d651c03d01d7e58657688c535e52bc59108f618' data-dcm-param-dvs5='1' data-dcm-param-dvs6='103' data-dcm-param-dvs7='${BUNDLE_ID}' data-dcm-param-dvs8='219374' data-dcm-param-dvs9='${INSERTION_ORDER_ID}' data-dcm-param-dvs10='11864' data-dcm-param-dvs11='${UNIVERSAL_SITE_ID}' data-dcm-param-dvs12='${EXCHANGE_ID}' data-dcm-param-dvs13='1404354615' data-dcm-param-dvs14='1404354615' data-dcm-param-dvs15='${INVENTORY_SOURCE_EXTERNAL_ID}'> <script src='https://www.googletagservices.com/dcm/dcmads.js'></script></ins></span><script src="https://cdn.doubleverify.com/dvtp_src.js?ctx=20515845&cmp=DV973873&sid=deepintent&plc=deepintent_im_disp_js&adsrv=0&advid=3891363&ppid=118&dvtagver=6.1.src&aufilter1=IM&autt=1&auevent=e6a44c05-028a-23b8-6d78-370f8f714f73&aubndl=&pltfrm=10067&auip=174.53.208.232&DVPX_PP_AUCTION_UA=Mozilla%2F5.0+%28Windows+NT+10.0%3B+Win64%3B+x64%29+AppleWebKit%2F537.36+%28KHTML%2C+like+Gecko%29+Chrome%2F142.0.0.0+Safari%2F537.36&turl=https%3A%2F%2Fwww.imdb.com%2Ftitle%2Ftt4574334%2Fepisodes%2F%3Fseason%3D2%26ref_%3Dttep" type="text/javascript"></script><div id='aeopt' style='position:absolute;z-index:9010;background-color:#CCCCCCCC;top:0;right:0;border-radius:0 0 0 5px;'><div id='aeopti' style='display:block;'><a href='https://www.deepintent.com/adchoices?payload=XY1364L8Yxf7jepisPuhaS22h2cUXvHT9FK9gycG-lBdyI8R4%2C112%2Cdi_85464279bc6145cdb6ec1%2C1%2CU080599873%2C114%2CID5-ZHMO1WZDyN72goF18rRh4LcWd3rBfmpuL3I06HCR8w%2C147%2C174.53.208.232%2C4%2Cfafd5422-9c55-4fc1-90b1-ac157ac26f6a%2C135%2Chc_1f2e9e82b134e30d917909329bc7b2fb%2C7%2CTH_15596557%2C121%2CF087ECCCDFD76D1DB3FBA7539375CDA0E49DD1E4289280FC556487EB66E2B49B%2C10%2CEDI_3fwEN42cz0D%252FkhFSd%252FIstTBObX4F68zAy1HZ%252FmTSgvqLacvmhp0NmUzO3XnwHbFX%2C14%2CEH_glrw35nP8t2uaWq6CNDbSxXg9xYMH4yfR69Of9E7ZY8lEYLBrFkf8kByyVFMYl1V%2C15%2C1dcd3cf3d488e610e0cab01b2af1d659' target='_blank' style='display:block;padding:1px 2px 1px 5px;'><img src='https://cdn.deepintent.com/adchoices/di-adchoices.png' alt='AdChoices' border='0' width='13' height='13' style='display:block;'></a></div></div></div></span><script type='text/javascript'>window.DeepIntentExecuteClicks=window.DeepIntentExecuteClicks||function(e){if(e)for(var n=e.split(','),t=0;t<n.length;t++)if(n[t])(new Image).src=n[t]};</script><noscript><img src='https://useast-beacon.deepintent.com/impression/e6a44c05-028a-23b8-6d78-370f8f714f73?ts=1762992395645&wp=TRACK' height='0px' width='0px' style='display:none' referrerpolicy='no-referrer-when-downgrade'></noscript><script type="text/javascript">(function(){var r;try{r=window.location.ancestorOrigins[window.location.ancestorOrigins.length-1];}catch(e){}new Image().src='https://useast-beacon.deepintent.com/impression/e6a44c05-028a-23b8-6d78-370f8f714f73?ts=1762992395645&wp=TRACK'+((typeof r==='string')?'&rf='+r:'');})();</script><iframe src='https://cdn.deepintent.com/syncpixel.html?_di_cfg=a' width='0' height='0' style='display:none;'></iframe>
</div><div style="height:0px;width:0px;overflow:hidden"><iframe src="https://eus.rubiconproject.com/usync.html?&geo=na&co=us" frameborder="0" marginwidth="0" marginheight="0" scrolling="NO" width="0" height="0" style="height:0px;width:0px"></iframe></div>
Creatives
